IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 21.61

Change

+0.18 (+0.85)%

Market Cap

USD 0.04B

Volume

4.30K

Analyst Target

N/A
Analyst Rating

Sell

ducovest Verdict
Created with Highstock 5.0.6

Very Bearish

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
IBBQ QQQ
  • QQQ
Relative Returns (From:    To: 2025-01-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-2.03 (-3.40%)

USD 54.00B
QQQM Invesco NASDAQ 100 ETF

-6.34 (-2.91%)

USD 38.66B
JEPQ JPMorgan Nasdaq Equity Premium..

-1.21 (-2.08%)

USD 20.93B
ACWI iShares MSCI ACWI ETF

-1.46 (-1.20%)

USD 19.52B
CGABL The Carlyle Group Inc. 4.625% ..

+0.22 (+1.17%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-24.70 (-33.78%)

USD 5.86B
TBIL Rbb Fund Inc - Us Treasury 3 M..

-0.01 (-0.02%)

USD 4.78B
TSLL Direxion Shares ETF Trust - Di..

-1.27 (-4.69%)

USD 4.68B
ETHA iShares Ethereum Trust ETF

-1.46 (-5.78%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

-0.38 (-0.52%)

USD 2.37B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.42% 76% C+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.42% 76% C+ 68% D+
Trailing 12 Months  
Capital Gain -3.40% 27% F 45% F
Dividend Return 0.82% 22% F 15% F
Total Return -2.57% 23% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.54% 46% F 40% F
Dividend Return 0.87% 40% F 36% F
Total Return 0.33% 26% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 12.17% 49% F 86% B+
Risk Adjusted Return 7.13% 37% F 38% F
Market Capitalization 0.04B 54% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.